JPWO2018159417A1 - 針状ヒドロキシアパタイトを含む複合材料成形体の製造方法及び複合材料成形体 - Google Patents
針状ヒドロキシアパタイトを含む複合材料成形体の製造方法及び複合材料成形体 Download PDFInfo
- Publication number
- JPWO2018159417A1 JPWO2018159417A1 JP2019502912A JP2019502912A JPWO2018159417A1 JP WO2018159417 A1 JPWO2018159417 A1 JP WO2018159417A1 JP 2019502912 A JP2019502912 A JP 2019502912A JP 2019502912 A JP2019502912 A JP 2019502912A JP WO2018159417 A1 JPWO2018159417 A1 JP WO2018159417A1
- Authority
- JP
- Japan
- Prior art keywords
- composite material
- mixture
- molded body
- material molded
- molded article
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 98
- 229910052588 hydroxylapatite Inorganic materials 0.000 title claims abstract description 56
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 title claims abstract description 56
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 claims abstract description 79
- 239000001913 cellulose Substances 0.000 claims abstract description 52
- 229920002678 cellulose Polymers 0.000 claims abstract description 52
- 238000000465 moulding Methods 0.000 claims abstract description 52
- 239000002121 nanofiber Substances 0.000 claims abstract description 52
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 47
- 239000003125 aqueous solvent Substances 0.000 claims abstract description 41
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 41
- 238000001035 drying Methods 0.000 claims abstract description 40
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 23
- 229910000389 calcium phosphate Inorganic materials 0.000 claims abstract description 20
- 238000002156 mixing Methods 0.000 claims abstract description 20
- 229940043430 calcium compound Drugs 0.000 claims abstract description 19
- 150000001674 calcium compounds Chemical class 0.000 claims abstract description 19
- 235000011010 calcium phosphates Nutrition 0.000 claims abstract description 19
- -1 calcium phosphate compound Chemical class 0.000 claims abstract description 18
- 239000002904 solvent Substances 0.000 claims abstract description 13
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 12
- 239000011575 calcium Substances 0.000 claims description 31
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 229910052698 phosphorus Inorganic materials 0.000 abstract description 8
- 239000011574 phosphorus Substances 0.000 abstract description 7
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 abstract description 6
- 239000000463 material Substances 0.000 description 29
- 230000000052 comparative effect Effects 0.000 description 20
- 239000002994 raw material Substances 0.000 description 14
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 13
- 210000000988 bone and bone Anatomy 0.000 description 12
- 239000000920 calcium hydroxide Substances 0.000 description 12
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 12
- 235000019700 dicalcium phosphate Nutrition 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 9
- 238000010304 firing Methods 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 238000013329 compounding Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000012620 biological material Substances 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000002441 X-ray diffraction Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000004570 mortar (masonry) Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 5
- 235000019731 tricalcium phosphate Nutrition 0.000 description 5
- 229940078499 tricalcium phosphate Drugs 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 238000005452 bending Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000000635 electron micrograph Methods 0.000 description 4
- 239000011812 mixed powder Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 229910014497 Ca10(PO4)6(OH)2 Inorganic materials 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 229910052586 apatite Inorganic materials 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001054 cortical effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000001027 hydrothermal synthesis Methods 0.000 description 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- LFULEKSKNZEWOE-UHFFFAOYSA-N propanil Chemical compound CCC(=O)NC1=CC=C(Cl)C(Cl)=C1 LFULEKSKNZEWOE-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002522 Wood fibre Polymers 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003462 bioceramic Substances 0.000 description 1
- 229920006167 biodegradable resin Polymers 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- ROPDWRCJTIRLTR-UHFFFAOYSA-L calcium metaphosphate Chemical compound [Ca+2].[O-]P(=O)=O.[O-]P(=O)=O ROPDWRCJTIRLTR-UHFFFAOYSA-L 0.000 description 1
- JJIQGEZLLWXYKV-UHFFFAOYSA-N calcium;dinitrate;hydrate Chemical compound O.[Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O JJIQGEZLLWXYKV-UHFFFAOYSA-N 0.000 description 1
- VMLAJPONBZSGBD-UHFFFAOYSA-L calcium;hydrogen carbonate;hydroxide Chemical compound [OH-].[Ca+2].OC([O-])=O VMLAJPONBZSGBD-UHFFFAOYSA-L 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000009694 cold isostatic pressing Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000007561 laser diffraction method Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000392 octacalcium phosphate Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 238000013001 point bending Methods 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 238000001144 powder X-ray diffraction data Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- YIGWVOWKHUSYER-UHFFFAOYSA-F tetracalcium;hydrogen phosphate;diphosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].OP([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O YIGWVOWKHUSYER-UHFFFAOYSA-F 0.000 description 1
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000002025 wood fiber Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/71—Ceramic products containing macroscopic reinforcing agents
- C04B35/78—Ceramic products containing macroscopic reinforcing agents containing non-metallic materials
- C04B35/80—Fibres, filaments, whiskers, platelets, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/42—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
- A61L27/425—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of phosphorus containing material, e.g. apatite
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
- C01B25/16—Oxyacids of phosphorus; Salts thereof
- C01B25/26—Phosphates
- C01B25/32—Phosphates of magnesium, calcium, strontium, or barium
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B28/00—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements
- C04B28/34—Compositions of mortars, concrete or artificial stone, containing inorganic binders or the reaction product of an inorganic and an organic binder, e.g. polycarboxylate cements containing cold phosphate binders
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/01—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics
- C04B35/447—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics based on phosphates, e.g. hydroxyapatite
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
- C04B35/636—Polysaccharides or derivatives thereof
- C04B35/6365—Cellulose or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2111/00—Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
- C04B2111/00474—Uses not provided for elsewhere in C04B2111/00
- C04B2111/00836—Uses not provided for elsewhere in C04B2111/00 for medical or dental applications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/50—Constituents or additives of the starting mixture chosen for their shape or used because of their shape or their physical appearance
- C04B2235/52—Constituents or additives characterised by their shapes
- C04B2235/5208—Fibers
- C04B2235/5212—Organic
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/60—Aspects relating to the preparation, properties or mechanical treatment of green bodies or pre-forms
- C04B2235/602—Making the green bodies or pre-forms by moulding
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/60—Aspects relating to the preparation, properties or mechanical treatment of green bodies or pre-forms
- C04B2235/604—Pressing at temperatures other than sintering temperatures
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/60—Aspects relating to the preparation, properties or mechanical treatment of green bodies or pre-forms
- C04B2235/606—Drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
- Y02W30/00—Technologies for solid waste management
- Y02W30/50—Reuse, recycling or recovery technologies
- Y02W30/91—Use of waste materials as fillers for mortars or concrete
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Ceramic Engineering (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Structural Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Composite Materials (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
調合工程S1では、少なくとも、α−リン酸三カルシウムを含むリン酸カルシウム化合物、水酸化カルシウム等のリンを含まないカルシウム化合物、セルロースナノファイバー、並びに、水及び/又は親水性溶媒からなる水系溶媒を混合して混合物を得る。混合方法は各材料を充分に混合できる方法であれば特に限定されない。混合は、例えば撹拌機、ハンドミキサー、自動乳鉢等を用いて撹拌することにより行うことができる。混合方法は、セルロースナノファイバーにダメージを与えない方法であれば特に限定されない。例えば、ホモジナイザーのようなセルロースナノファイバーにダメージを与えるおそれがある混合方法は好ましくない。
除去工程S2では、調合工程S1で作製した混合物から、当該混合物に含まれる水系溶媒の一部もしくは全てを除去する。水系溶媒の除去方法としては、乾燥、濾過、遠心分離等の方法が挙げられる。乾燥方法としては、常温常圧での乾燥、加温による乾燥、減圧乾燥、凍結乾燥等が挙げられる。これらの方法で水系溶媒を除去することで、混合物を、水系溶媒を含まない混合粉末としてもよい。また、調合工程S1において自動乳鉢で原料の混合を行った場合、そのまま自動乳鉢により常温常圧で粉末状になるまで撹拌を続けることで、水系溶媒を除去してもよい。なお、α−リン酸三カルシウムがヒドロキシアパタイトに転化することを抑制する観点から、除去工程は、40℃以下の温度で行うことが好ましく、常温(25℃)以下の温度で行うことがより好ましい。
成形工程S3で用いる混合物は、除去工程S2により水系溶媒が除去された混合物、もしくは水系溶媒がある程度残っている混合物のどちらでもよい。成形工程S3では、これらの混合物(原料混合物)を成形して成形体を得る。成形は、プレス成形により行うことが好ましい。プレス成形は、水系溶媒が除去された混合粉末を加圧することで行うことができる。また、水系溶媒を含んだ状態であっても100℃程度に加熱して水系溶媒を揮発させながら加圧することで、プレス成形を行ってもよい。また、常温で成形した後、乾燥させてもよい。更に、成形は、減圧しながら行ってもよい。
乾燥工程S4では、成形工程S3で作製した成形体を脱型し、乾燥機内にて常温〜50℃、好ましくは30〜50℃、より好ましくは40〜50℃の温度で24〜48時間乾燥させる。
合成工程S5では、乾燥工程S4で乾燥した成形体を、密閉容器内で、好ましくは120℃以下、より好ましくは60〜120℃、更に好ましくは80〜100℃の温度で6〜120時間水蒸気と接触させる処理により合成を行う。上記の条件で合成を行うことにより、α−リン酸三カルシウムを針状ヒドロキシアパタイトに転化させることができる。合成工程S5では、オートクレーブのような大掛かりな装置は必要とせず、密閉可能な容器を特に制限なく用いることができる。
第2の乾燥工程S6では、合成後の成形体を、乾燥機内にて常温〜50℃、好ましくは、30〜50℃の温度で6時間以上乾燥させる。これにより、成形体に残存した水系溶媒、及び、合成時に成形体に付着した水分を除去する。
セルロースナノファイバー20質量部(固形分)を蒸留水900質量部に充分に分散させた後、α−リン酸三カルシウム90.12質量部及びリン酸水素カルシウム9.88質量部(α−リン酸三カルシウムとリン酸水素カルシウムのモル比=4:1)、並びに、所定量の水酸化カルシウムを添加し、ハンドミキサーで5分間撹拌混合して混合物を調合した(調合工程)。ここで、水酸化カルシウムの配合量は、得られる混合物のCa/P比が1.67となる量とした。
セルロースナノファイバー20質量部(固形分)を蒸留水900質量部に充分に分散させた後、α−リン酸三カルシウム100質量部、及び、所定量の水酸化カルシウムを添加し、ハンドミキサーで5分間撹拌混合して混合物を調合した(調合工程)。ここで、水酸化カルシウムの配合量は、得られる混合物のCa/P比が1.67となる量とした。上記調合工程で得られた混合物を用いたこと以外は実施例1と同様にして除去工程、成形工程、乾燥工程、合成工程及び第2の乾燥工程を行い、針状ヒドロキシアパタイトとセルロースナノファイバーとを含む複合材料成形体を得た。
セルロースナノファイバー20質量部(固形分)を蒸留水900質量部に充分に分散させた後、リン酸水素カルシウム100質量部、及び、所定量の水酸化カルシウムを添加し、ハンドミキサーで5分間撹拌混合して混合物を調合した(調合工程)。ここで、水酸化カルシウムの配合量は、得られる混合物のCa/P比が1.67となる量とした。上記調合工程で得られた混合物を用いたこと以外は実施例1と同様にして除去工程、成形工程、乾燥工程、合成工程及び第2の乾燥工程を行い、複合材料成形体を得た。
ヒドロキシアパタイト100質量部とセルロースナノファイバー20質量部(固形分)と蒸留水900質量部とをハンドミキサーで5分間撹拌混合し、混合物を調合した(調合工程)。上記調合工程で得られた混合物を用いたこと以外は実施例1と同様にして除去工程、成形工程、乾燥工程、合成工程及び第2の乾燥工程を行い、複合材料成形体を得た。
(粒子状骨材)
α−リン酸三カルシウム(α−TCP):Ca3(PO4)2、太平化学産業(株)製、Ca/P比=1.5
リン酸水素カルシウム(無水リン酸水素カルシウム、DCPA):CaHPO4、太平化学産業(株)製、Ca/P比=1
ヒドロキシアパタイト(HAp):Ca10(PO4)6(OH)2、太平化学産業(株)製、Ca/P比=1.67
水酸化カルシウム:Ca(OH)2、和光純薬工業(株)製
(フィラー)
セルロースナノファイバー:(株)スギノマシン製、商品名「ビンフィス」
実施例及び比較例で得られた複合材料成形体について、走査型電子顕微鏡(日本電子株式会社製、型式JSM−7500F)を用いて観察した。図4〜7に、実施例1〜2及び比較例1〜2で得られた複合材料成形体の断面(内部)の走査型電子顕微鏡(SEM)写真(倍率:1000、3000、30000倍)を示す。図4〜7中の(a)、(b)及び(c)は、それぞれ倍率を変えて撮影したSEM写真であり、(a)が1000倍、(b)が3000倍、(c)が30000倍の倍率である。図4(実施例1)及び図5(実施例2)から、実施例1及び2で得られた複合材料成形体の内部には、針状の析出物(直径約50nm、長さ500nm)が絡み合って析出していることが確認できる。一方、図6(比較例1)及び図7(比較例2)から、比較例1及び2で得られた複合材料成形体の内部には針状の析出物が確認できなかった。
実施例及び比較例で得られた複合材料成形体を、8±1mm×40±1mm×厚さ2.2±0.5mmの板状の試験片に加工した。この試験片について、強度試験(インストロン社製、商品名「INSTRON5566」)を用いて、三点曲げ試験を行った。測定条件は、支点間距離:15±2mm、測定速度(ヘッドの移動速度):1.00mm/min、測定温度:室温(10〜35℃)とした。5本の試験片の平均値を求めて測定結果とした。結果を表1に示す。
セルロースナノファイバー20質量部(固形分)を蒸留水900質量部に充分に分散させた後、α−リン酸三カルシウム90.12質量部及びリン酸水素カルシウム9.88質量部(α−リン酸三カルシウムとリン酸水素カルシウムのモル比=4:1)、並びに、所定量の水酸化カルシウムを添加し、自動乳鉢で30分間以上撹拌混合して混合物を調合した(調合工程)。ここで、水酸化カルシウムの配合量は、得られる混合物のCa/P比が1.67となる量とした。
Claims (9)
- 少なくとも、α−リン酸三カルシウムを含むリン酸カルシウム化合物、リンを含まないカルシウム化合物、セルロースナノファイバー、並びに、水及び/又は親水性溶媒からなる水系溶媒を混合して混合物を得る調合工程と、
前記混合物を用いて成形体を形成する成形工程と、
前記成形体を乾燥させる乾燥工程と、
乾燥後の前記成形体を合成処理する合成工程と、
を有する、針状ヒドロキシアパタイトを含む複合材料成形体の製造方法。 - 前記調合工程において、前記カルシウム化合物を前記混合物のCa/P比が1.50超1.80以下となるように添加する、請求項1に記載の製造方法。
- 前記調合工程において、前記セルロースナノファイバーを前記リン酸カルシウム化合物100質量部に対して10〜40質量部添加する、請求項1又は2に記載の製造方法。
- 前記成形工程の前に、前記混合物から前記水系溶媒の一部又は全てを除去する除去工程を有する、請求項1〜3のいずれか一項に記載の製造方法。
- 前記成形工程において、前記混合物をプレス成形しながら前記水系溶媒の一部又は全てを除去して前記成形体を形成する、請求項1〜4のいずれか一項に記載の製造方法。
- 前記合成工程において、乾燥後の前記成形体を60〜120℃の温度で合成処理する、請求項1〜5のいずれか一項に記載の製造方法。
- 針状ヒドロキシアパタイトとセルロースナノファイバーとを含む、複合材料成形体。
- Ca/P比が1.50超1.80以下である、請求項7に記載の複合材料成形体。
- 前記セルロースナノファイバー同士が水素結合した構造を有する、請求項7又は8に記載の複合材料成形体。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017036937 | 2017-02-28 | ||
JP2017036937 | 2017-02-28 | ||
PCT/JP2018/006269 WO2018159417A1 (ja) | 2017-02-28 | 2018-02-21 | 針状ヒドロキシアパタイトを含む複合材料成形体の製造方法及び複合材料成形体 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2018159417A1 true JPWO2018159417A1 (ja) | 2019-12-19 |
JP6915677B2 JP6915677B2 (ja) | 2021-08-04 |
Family
ID=63371368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019502912A Active JP6915677B2 (ja) | 2017-02-28 | 2018-02-21 | 針状ヒドロキシアパタイトを含む複合材料成形体の製造方法及び複合材料成形体 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20200000961A1 (ja) |
JP (1) | JP6915677B2 (ja) |
KR (1) | KR102455255B1 (ja) |
CN (1) | CN110114309B (ja) |
WO (1) | WO2018159417A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020234622A1 (en) * | 2019-05-17 | 2020-11-26 | Sri Lanka Institute Of Nanotechnology | Asbestos free nano-hybrid for fiber-cement composite applications |
KR102448241B1 (ko) | 2020-05-13 | 2022-09-28 | (주)바이오리진 | 이중구조를 갖는 이상 인산칼슘 다공체와 이의 제조방법 그리고 이를 이용한 합성골의 제조방법 |
KR102493845B1 (ko) | 2020-07-16 | 2023-01-31 | 충남대학교산학협력단 | 형광 수산화아파타이트 및 이의 제조방법 |
WO2022138906A1 (ja) * | 2020-12-25 | 2022-06-30 | 東亞合成株式会社 | 無機成形体及び無機成形体用バインダー |
JP7270689B2 (ja) * | 2021-08-18 | 2023-05-10 | 中越パルプ工業株式会社 | Cnf成形体の製造方法、cnf成形体及び象牙代替材料としてのcnf成形体 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07132140A (ja) * | 1993-11-09 | 1995-05-23 | Kyoritsu Yogyo Genryo Kk | 医療用補綴材料 |
JPH07232060A (ja) * | 1993-10-21 | 1995-09-05 | Takeda Chem Ind Ltd | 化学物質吸着シートの製造法 |
JP2001287903A (ja) * | 2000-04-05 | 2001-10-16 | Asahi Kasei Corp | 針状アパタイト粒子の製造方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002274822A (ja) | 2001-03-23 | 2002-09-25 | Asahi Kasei Corp | 針状アパタイト粒子の製造方法 |
ES2346973T3 (es) * | 2003-06-24 | 2010-10-22 | Kyushu University, National University Corporation | Material protesico oseo medico y procedimiento de produccion del mismo. |
JP4647603B2 (ja) | 2003-08-08 | 2011-03-09 | デンツプリー・インターナショナル・インコーポレーテッド | 歯科用セメントや関連した骨セメントに使用するホスホシリケートスラリーを得るための方法と製造物 |
US20080146701A1 (en) | 2003-10-22 | 2008-06-19 | Sain Mohini M | Manufacturing process of cellulose nanofibers from renewable feed stocks |
CN101721740A (zh) * | 2008-10-16 | 2010-06-09 | 上海国睿生命科技有限公司 | 一种骨组织工程支架材料及其制备方法和用途 |
CN101508429B (zh) * | 2009-03-13 | 2011-04-27 | 四川大学 | 羟基磷灰石纳米复合粒子及其制备方法与应用 |
DE102009039665A1 (de) * | 2009-09-02 | 2011-03-03 | Aap Biomaterials Gmbh | Hydroxylapatitmaterial sowie Verfahren zu dessen Herstellung |
CN105148324B (zh) * | 2015-08-31 | 2018-02-16 | 中原工学院 | 一种由矿化的纳米纤维素晶须构建的骨仿生材料及其制备方法 |
CN105935455A (zh) * | 2016-04-18 | 2016-09-14 | 北京林业大学 | 一种纤维素/羟基磷灰石纳米复合材料及其制备方法 |
-
2018
- 2018-02-21 US US16/484,282 patent/US20200000961A1/en not_active Abandoned
- 2018-02-21 JP JP2019502912A patent/JP6915677B2/ja active Active
- 2018-02-21 KR KR1020197018689A patent/KR102455255B1/ko active IP Right Grant
- 2018-02-21 CN CN201880005282.0A patent/CN110114309B/zh active Active
- 2018-02-21 WO PCT/JP2018/006269 patent/WO2018159417A1/ja active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07232060A (ja) * | 1993-10-21 | 1995-09-05 | Takeda Chem Ind Ltd | 化学物質吸着シートの製造法 |
JPH07132140A (ja) * | 1993-11-09 | 1995-05-23 | Kyoritsu Yogyo Genryo Kk | 医療用補綴材料 |
JP2001287903A (ja) * | 2000-04-05 | 2001-10-16 | Asahi Kasei Corp | 針状アパタイト粒子の製造方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110114309A (zh) | 2019-08-09 |
US20200000961A1 (en) | 2020-01-02 |
KR102455255B1 (ko) | 2022-10-18 |
KR20190124700A (ko) | 2019-11-05 |
WO2018159417A1 (ja) | 2018-09-07 |
CN110114309B (zh) | 2022-11-01 |
JP6915677B2 (ja) | 2021-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6915677B2 (ja) | 針状ヒドロキシアパタイトを含む複合材料成形体の製造方法及び複合材料成形体 | |
Joseph Nathanael et al. | Enhanced mechanical strength of hydroxyapatite nanorods reinforced with polyethylene | |
Rajkumar et al. | Preparation of size controlled, stoichiometric and bioresorbable hydroxyapatite nanorod by varying initial pH, Ca/P ratio and sintering temperature | |
CN1240637C (zh) | 多孔磷酸钙生物陶瓷材料及其制备方法 | |
Sánchez-Salcedo et al. | Design and preparation of biocompatible zwitterionic hydroxyapatite | |
WO1995023775A1 (fr) | CERAMIQUE DE PHOSPHATE TRICALCIQUE DE TYPE α ET SON PROCEDE DE PRODUCTION | |
Bingöl et al. | Hydrothermal synthesis of hydroxyapatite from calcium sulfate hemihydrate | |
Chen et al. | Synthesis of fiber-like monetite without organic additives and its transformation to hydroxyapatite | |
CN101891175A (zh) | 牙釉质状羟基磷灰石及其制备方法和应用 | |
CN104446432A (zh) | 一种磁性羟基磷灰石生物陶瓷及其制备方法 | |
Zaman et al. | Fabrication of B-type carbonate apatite blocks by the phosphorization of free-molding gypsum-calcite composite | |
Hapuhinna et al. | Development of a biomaterial from naturally occurring chloroapatite mineral for biomedical applications | |
Rahim et al. | Eggshell Derived Calcium Phosphate and Its Conversion to Dense Bodies | |
Marahat et al. | Effect of magnesium ion (Mg2+) substitution and calcination to the properties of biphasic calcium phosphate (BCP) | |
Jain | Processing of hydroxyapatite by biomimetic process | |
Ragu et al. | Synthesis and characterization of nano hydroxyapatite with polyurethane nano composite | |
KR100759718B1 (ko) | 수열 열간 가압법을 이용한 인산칼슘계 다공체 및 그 제조방법 | |
Othman et al. | Effect of calcination temperatures on phase transformation and stability of β-tricalcium phosphate powder synthesized by a wet precipitation method | |
CN108273128A (zh) | 自固化磷酸钙骨修复材料 | |
Marahat et al. | Effect of Sintered Magnesium Substituted Biphasic Calcium Phosphate (Mg-BCP) | |
JP2638619B2 (ja) | 自己硬化型高強度複合生体材料とその製造方法 | |
Nawawi et al. | Densification of Calcium Phosphate from Biogenic Waste for Biomedical Application. | |
Ishikawa et al. | Inga Grigoraviciute-Puroniene, Yuhei Tanaka 2, Visata Vegelyte, Yuko Nishimoto 2 | |
Ghosal | Densification and mechanical characterization of pure and doped hydroxyapatite | |
JPH0337171A (ja) | 複合セラミックスの製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200210 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210302 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210506 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210615 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210628 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6915677 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |